INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR REFRACTORY PSEUDOPHAKIC CYSTOID MACULAR EDEMA
- 1 March 2006
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Retina
- Vol. 26 (3), 356-357
- https://doi.org/10.1097/00006982-200603000-00018
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Neovascular Age-Related Macular DegenerationOphthalmic Surgery, Lasers and Imaging Retina, 2005
- Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edemaAmerican Journal of Ophthalmology, 2003
- Intravitreal triamcinolone for refractory pseudophakic macular edemaAmerican Journal of Ophthalmology, 2003
- Increased Intraocular Pressure Induced by Repository CorticosteroidsAmerican Journal of Ophthalmology, 1976